BrainStorm Cell Therapeutics
BCLI
#10708
Rank
A$15.44 M
Marketcap
A$1.40
Share price
6.52%
Change (1 day)
37.99%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2026 (TTM): -A$14.31 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$14.73 Million, an increase over its 2024 earnings that were of -A$16.61 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$14.31 Million-2.83%
2025 -A$14.73 Million-11.32%
2024 -A$16.61 Million-32.39%
2023 -A$24.56 Million-29.18%
2022 -A$34.68 Million-0.74%
2021 -A$34.94 Million-23.12%
2020 -A$45.45 Million36.8%
2019 -A$33.22 Million66.71%
2018 -A$19.93 Million181.66%
2017 -A$7.08 Million-0.6%
2016 -A$7.12 Million-41.31%
2015 -A$12.13 Million-8.22%
2014 -A$13.22 Million89.74%
2013 -A$6.97 Million42.27%
2012 -A$4.9 Million-12.45%
2011 -A$5.59 Million63.04%
2010 -A$3.43 Million35.52%
2009 -A$2.53 Million-48.99%
2008 -A$4.96 Million-44.39%
2007 -A$8.92 Million
2005 -A$4.62 Million-91.44%
2004 -A$53.97 Million94007.62%
2003 -A$0.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Biogen
BIIB
A$2.31 B-17,059.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$15.32 B-112,200.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-A$1.13 Billion 8,160.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-A$1.19 Billion 8,568.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
A$0.17 B-1,350.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-A$0.37 Billion 2,569.69%๐Ÿ‡บ๐Ÿ‡ธ USA